Overview
Top Medical Research Studies
Our observations revealed that administering Vitamin D3 helped reduce damage to the thyroid and decreased the presence of inflammatory cells within the thyroid. This treatment also led to lower levels of thyroid hormones and autoimmune antibodies in the blood, highlighting its positive effect on thyroid function. Additionally, Vitamin D3 appeared to promote the regulatory T cell (Treg) subset while decreasing the levels of Th17 cells, which are often involved in autoimmune processes.
Mechanistically, the study found that Vitamin D3 triggered specific pathways that influence Treg cell activity and survival. Notably, it activated a signaling pathway involving YAP and JAK/STAT, which are crucial for immune cell regulation. These findings suggest that Vitamin D3 could play a significant role in balancing immune responses in autoimmune thyroiditis, making it a promising candidate for further research and potential treatment strategies.
After 8 weeks of treatment, we observed that vitamin D3 significantly improved the condition of the thyroid in these mice. The inflammation that commonly accompanies autoimmune thyroiditis decreased, and levels of thyroid autoantibodies, which indicate the severity of the disorder, also dropped. Notably, the application of vitamin D3 inhibited the activity of harmful immune cells while promoting the function of protective cells, providing a better balance in the immune response.
Overall, our findings suggest that vitamin D3 supplementation could be a promising strategy to manage autoimmune thyroiditis by restoring immune balance and reducing inflammation. This not only enhances our understanding of the disease but also opens up potential avenues for treatment in humans facing similar issues with autoimmune disorders.
Through our investigation using a mouse model, we observed that injecting these vitamin D3-modulated dendritic cells, which overexpress a molecule called PD-L1, significantly lessened liver injury and severity of autoimmune hepatitis. This treatment appeared to correct the imbalance between two types of T cells: regulatory T cells (TFR) and follicular helper T cells (TFH).
By increasing the TFR population and restoring their balance with TFH cells, vitamin D3 treatment helped regulate this immune response. Additionally, the infusion boosted the production of anti-inflammatory substances while decreasing those linked to inflammation, suggesting a potential new avenue for treating autoimmune hepatitis. Overall, these findings indicate that vitamin D3-modulated dendritic cells could be a promising strategy for managing autoimmune conditions like AIH.
Most Useful Reviews
Medical Researches
- All Researches
Our findings revealed that alfacalcidol significantly improved bone mineral density and reduced fracture rates compared to plain vitamin D. For instance, the alfacalcidol group experienced better increases in spine and hip bone density, and fewer new fractures overall.
Side effects were mild in both groups, affirming that alfacalcidol is more beneficial and should replace plain vitamin D as a treatment option.
Through a process called hydrolysis, CSNs release several beneficial components, including hydrogen gas, calcium hydroxide, and silica. Each of these components contributes uniquely: hydrogen helps reduce harmful radicals and aids in adjusting surrounding immune cell behavior; calcium hydroxide counters the acidity that can worsen bone loss; and dissolved calcium works with phosphates to encourage bone formation.
We found that the application of CSNs had promising results in tests conducted on both mouse and rabbit models of arthritis. This approach not only targets inflammation but also fosters a healthier bone environment, showing potential as a strong therapeutic option for those living with RA. With high biocompatibility and prospects for clinical transformation, this research suggests a new direction in handling autoimmune disorders using calcium-based therapies.
After 8 weeks of treatment, we observed that vitamin D3 significantly improved the condition of the thyroid in these mice. The inflammation that commonly accompanies autoimmune thyroiditis decreased, and levels of thyroid autoantibodies, which indicate the severity of the disorder, also dropped. Notably, the application of vitamin D3 inhibited the activity of harmful immune cells while promoting the function of protective cells, providing a better balance in the immune response.
Overall, our findings suggest that vitamin D3 supplementation could be a promising strategy to manage autoimmune thyroiditis by restoring immune balance and reducing inflammation. This not only enhances our understanding of the disease but also opens up potential avenues for treatment in humans facing similar issues with autoimmune disorders.
Interestingly, despite normal serum IgG4 levels, which were below 135 mg/dL, the clinical and imaging findings strongly suggested the diagnosis of IgG4-RD. This scenario underscores the importance of undertaking a biopsy for accurate diagnosis. Histopathological examination revealed notable signs, such as a dense lymphoplasmacytic infiltrate and storiform fibrosis, with a considerable percentage of IgG4-positive cells, ultimately confirming our diagnosis.
We observed that treatment with prednisone, alongside azathioprine for long-term control, was effective. To mitigate the risk of glucocorticoid-induced osteoporosis, we added calcium and vitamin D3 supplementation. Remarkably, the patient showed significant clinical improvement within just 24 hours, with resolution of orbital and glandular symptoms over the following year. There was a complete recovery of vision and no relapses, with only minor dry eye as a long-term concern.
This case demonstrates the necessity of considering IgG4-RD even when serum IgG4 levels are normal and highlights the role of histopathology in diagnosis. Furthermore, it showcases the effectiveness of corticosteroids as a first-line treatment in managing this condition.
After conducting our experiments, we found that MSCs treated with calcitriol demonstrated improved regulatory functions and inhibited inflammatory responses more effectively than untreated MSCs. Specifically, we observed differences in the behavior of immune cells, with calcitriol-treated cells showing reduced levels of certain inflammatory cytokines, like INF-γ and IL-17, while increasing beneficial cytokines such as IL-4, IL-10, and TGF-β.
These findings suggest that vitamin D3 may play an important role in moderating the immune response in autoimmune conditions like rheumatoid arthritis, potentially offering a pathway for more effective treatment options.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
An autoimmune disorder occurs when the body's immune system mistakenly attacks its own healthy cells and tissues, believing them to be foreign invaders, such as bacteria or viruses. This reaction can lead to inflammation, tissue damage, and impaired function of the affected organs. There are over 80 known autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes, each with its own specific symptoms and treatment options. The exact cause of these disorders is still unclear, but a combination of genetic, environmental, and hormonal factors is believed to play a role in their development.
Diagnosis of autoimmune disorders often involves a combination of physical examinations, assessment of symptoms, blood tests, and imaging studies to evaluate organ involvement. Treatment typically focuses on managing symptoms and controlling the immune response using medications such as corticosteroids, immunosuppressants, and biologics. In addition to medication, lifestyle modifications, such as stress management and a balanced diet, can be beneficial in managing symptoms. If you suspect you have an autoimmune condition, it's important to consult a healthcare professional for proper evaluation and tailored treatment options.
Calcium Plus Vitamin D is a dietary supplement that combines calcium, an essential mineral vital for maintaining strong bones and teeth, with Vitamin D, a nutrient that enhances calcium absorption in the body. This combination is particularly beneficial for individuals looking to support their bone health, especially those at risk for osteoporosis or conditions that lead to decreased bone density. Calcium plays a key role in various bodily functions, including muscle contraction and nerve signaling, while Vitamin D aids in the regulation of calcium levels within the blood and helps promote overall immune function.
Many formulations of Calcium Plus Vitamin D are available in various forms, including tablets, capsules, and chewables, catering to different preferences and dietary needs. When considering adding a calcium and vitamin D supplement to your daily routine, it's essential to consult with a healthcare professional to ensure it's appropriate for your specific health requirements and to determine the right dosage. A balanced diet combined with regular sunlight exposure can also help maintain adequate calcium and vitamin D levels without the need for supplementation. However, for individuals who have limited sun exposure or have dietary restrictions, such supplements can provide a convenient and effective way to support bone health.
Based on user reviews, the timeframe for seeing results from this calcium supplement can vary, but many users report improvements within a few weeks. For instance, one reviewer indicated that they noticed a reduction in shoulder joint pain after just two weeks of use, despite having an autoimmune disorder (Read Review). Another user claimed that their leg cramps vanished within four days, showing early signs of the supplement's effectiveness (Read Review).
Additionally, some users noted more gradual improvements, with visible changes in nail health occurring after a month of consistent use (Read Review). It seems that most reviewers experienced noticeable benefits within a timeframe ranging from four days to one month, suggesting that while short-term effects can be felt quickly, longer-term use may lead to more significant changes in health and well-being.
The role of vitamin D supplementation in managing autoimmune disorders has garnered interest in recent years, with mixed results reported across various studies. For example, while a study focusing on patients with systemic lupus erythematosus found that increasing vitamin D levels was associated with a modest reduction in disease activity, the clinical significance of these improvements was limited, suggesting that higher vitamin D levels beyond a certain threshold may not yield further benefits [5]. Additionally, research examining patients with multiple sclerosis showed that despite achieving elevated vitamin D levels through supplementation, significant improvements in key clinical outcomes such as relapse rates and disability progression were not observed [26].
On the other hand, some studies indicate that vitamin D may improve immune response balance in autoimmune conditions. For instance, a study involving autoimmune thyroiditis demonstrated that vitamin D3 could decrease thyroid autoantibody levels, correlating with better management of the condition [28]. Another investigation into vitamin D's effects on autoimmune hepatitis highlighted its potential for moderating immune responses [19]. Together, these findings suggest that while vitamin D follows a promising trend in managing certain autoimmune disorders, its effectiveness is often conditional and may not universally apply across all conditions, warranting further exploration to establish clear therapeutic guidelines.
Based on user reviews, many individuals have reported various improvements in their health after using the calcium supplement, with results typically noted within a few weeks. For instance, one user shared that after three weeks of use, this calcium product restored their levels to normal, positively impacting their overall health (Read Review). Another reviewer noted visible enhancements in hair and nail health after combining the supplement with magnesium citrate, reinforcing its effectiveness (Read Review).
Users have also experienced relief from specific conditions, such as joint pain and skin issues. One user reported a complete disappearance of their leg pain due to osteoporosis within a week of starting the supplement (Read Review). Similarly, improvements in eczema were noted after over a month of usage, highlighting the supplement's potential therapeutic benefits (Read Review). While many have shared satisfying outcomes, it's important to remember that individual results may vary, and what works for one person may not work for another.
Based on user reviews, many individuals have reported positive outcomes when combining this calcium supplement with other supplements for addressing autoimmune disorders and related health concerns. For instance, one user noted that taking the supplement alongside magnesium citrate led to noticeable improvements in hair and nail health (Read Review). Another user indicated that a holistic regimen including calcium and vitamin D recommended by a healthcare professional enhanced their overall skin and hair condition (Read Review).
Users have also shared success stories related to specific conditions, such as eczema, which improved significantly after using calcium with vitamin D (Read Review). Moreover, one reviewer who suffered from fibromyalgia reported substantial relief by combining the calcium supplement with others, illustrating the effectiveness of a multi-supplement approach in managing autoimmune symptoms (Read Review). Overall, feedback suggests that pairing this calcium supplement with different nutrients can yield synergistic benefits, particularly for those facing autoimmune-related challenges.
Based on user reviews, individuals treating autoimmune disorders with Calcium Plus Vitamin D often report a need for specific dosage guidelines to maximize effectiveness. For instance, one user noted complete relief from shoulder joint pain after just two weeks of regular use, emphasizing that the simplicity of taking the supplement made it easier to integrate into daily routines, even amidst their health challenges (Read Review). Another user, who experienced improvements with symptoms linked to fibromyalgia, highlighted the collective benefit of seeking out complementary supplements alongside calcium, indicating that a tailored approach can yield positive results (Read Review).
Users also shared insights into their dosing experience. One review described a regimen involving one tablet for prophylactic purposes and two for therapeutic use, demonstrating that personalized dosing can cater to individual health needs and challenges (Read Review). While exact doses can vary, combining this supplement with proper guidance from healthcare professionals is essential for those managing autoimmune disorders. Overall, the consensus suggests that while users experienced benefits, adjustments in dosage may be crucial for optimal results and symptom relief.
At the conclusion of our trial, we observed a marked difference in serum vitamin D levels between the two groups. The calcifediol group achieved significantly higher concentrations of vitamin D, suggesting it is more effective in quickly raising vitamin D levels in MS patients compared to cholecalciferol.
However, we must report that despite these increased vitamin D levels, neither treatment group showed significant improvements in other important clinical measures such as MS relapses, disability progression, or overall quality of life. Both groups indeed indicated some improvements in cognitive function, but the major clinical outcomes remained largely unchanged.
Overall, our findings suggest that while calcifediol is better at increasing vitamin D levels, it did not lead to substantial improvements in the management of multiple sclerosis. Thus, further investigation may be needed to understand the broader implications of vitamin D treatment in autoimmune disorders like MS.
Research indicates that individuals with HT often have lower levels of vitamin D compared to those without the condition. When we examined cases where patients with HT and vitamin D deficiency received vitamin D3 supplementation, we noticed a promising trend. Specifically, it was found that thyroid autoantibody titers, which are markers of immune response against the thyroid, significantly decreased in these patients following supplementation.
However, it’s important to note that while these findings are encouraging, the overall understanding of vitamin D3’s role in treating autoimmune thyroid diseases is still developing. More rigorous studies, specifically randomized, double-blind, placebo-controlled trials with longer follow-up durations, are necessary to truly grasp the benefits of vitamin D3 in this context.
Through our investigation using a mouse model, we observed that injecting these vitamin D3-modulated dendritic cells, which overexpress a molecule called PD-L1, significantly lessened liver injury and severity of autoimmune hepatitis. This treatment appeared to correct the imbalance between two types of T cells: regulatory T cells (TFR) and follicular helper T cells (TFH).
By increasing the TFR population and restoring their balance with TFH cells, vitamin D3 treatment helped regulate this immune response. Additionally, the infusion boosted the production of anti-inflammatory substances while decreasing those linked to inflammation, suggesting a potential new avenue for treating autoimmune hepatitis. Overall, these findings indicate that vitamin D3-modulated dendritic cells could be a promising strategy for managing autoimmune conditions like AIH.
References
- Xiaowei L, Bo W, Li L, Peng Z. Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria. Int Urol Nephrol. 2020;52:129. doi:10.1007/s11255-019-02329-5
- Doosti-Irani A, Tamtaji OR, Mansournia MA, Ghayour-Mobarhan M, Ferns G, et al. The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials. Clin Neurol Neurosurg. 2019;187:105564. doi:10.1016/j.clineuro.2019.105564
- Nakamura Y, Suzuki T, Yoshida T, Yamazaki H, Kato H. Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis. Nutrients. 2017;9. doi:10.3390/nu9050428
- Grace-Farfaglia P. Bones of contention: bone mineral density recovery in celiac disease--a systematic review. Nutrients. 2015;7:3347. doi:10.3390/nu7053347
- Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 2013;65:1865. doi:10.1002/art.37953
- Kimball S, Vieth R, Dosch HM, Bar-Or A, Cheung R, et al. Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. J Clin Endocrinol Metab. 2011;96:2826. doi:10.1210/jc.2011-0325
- Ledwich LJ, Clarke K. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. J Clin Rheumatol. 2009;15:61. doi:10.1097/RHU.0b013e31819b65bd
- Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, et al. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol. 2008;35:2344. doi:10.3899/jrheum.080634
- Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, et al. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. Arthritis Rheum. 2008;58:3255. doi:10.1002/art.23809
- Ringe JD, Faber H, Fahramand P, Schacht E. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. J Rheumatol Suppl. 2005;76:33.
- Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, et al. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound. Bone. 2003;33:575.
- Kung AW, Chan TM, Lau CS, Wong RW, Yeung SS. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy. Rheumatology (Oxford). 1999;38:1239.
- Dottori L, D'Ottavio D, Brundisini B. [Calcifediol and calcitonin in the therapy of rheumatoid arthritis. A short-term controlled study]. Minerva Med. 1982;73:3033.
- Vernerová L, Vokurková M, Laiferová NA, Nemec M, Špiritović M, et al. Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis. Arthritis Res Ther. 2025;27:48. doi:10.1186/s13075-025-03516-9
- Wang CM, Chen YJ, Yang BC, Yang JW, Wang W, et al. Supplementation with active vitamin D3 ameliorates experimental autoimmune thyroiditis in mice by modulating the differentiation and functionality of intrathyroidal T-cell subsets. Front Immunol. 2025;16:1528707. doi:10.3389/fimmu.2025.1528707
- Mendoza-Vargas LÁ, Sevilla-Fuentes S, Bautista-Becerril B, Berthaúd-González B, Falfán-Valencia R, et al. IgG4-RD-Associated Mikulicz Syndrome Without Classic Systemic Involvement-A Case Report. J Clin Med. 2025;14. doi:10.3390/jcm14030958
- Rafati A, Ramezani R, Esmaeili Gouvarchin Ghaleh H, Bahrami S, Alvanegh AG, et al. Calcitriol Treated Mesenchymal Stem Cells Modulated Immune Response in Collagen-Induced Rheumatoid Arthritis in BALB/c Mice. Transplant Proc. 2025;57:355. doi:10.1016/j.transproceed.2024.12.020
- Kilani Y, Alsakarneh S, Madi MY, Mosquera DAG, Ferreira MN, et al. Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective. Aliment Pharmacol Ther. 2025;61:682. doi:10.1111/apt.18438
- Dai J, Song J, Chen X, Ding F, Ding Y, et al. 1,25(OH)D-treated mouse bone marrow-derived dendritic cells alleviate autoimmune hepatitis in mice by improving TFR/TFH imbalance. Immunopharmacol Immunotoxicol. 2025;47:59. doi:10.1080/08923973.2024.2435314
- Wielińska J, Górna K, Świerkot J, Bugaj B, Kolossa K, et al. Polymorphic Variants in the Vitamin D Receptor and Clinical Parameters of Rheumatoid Arthritis Patients Undergoing Anti-TNF Treatment. Arch Immunol Ther Exp (Warsz). 2024;72. doi:10.2478/aite-2024-0023
- Yu ZQ, Du HX, Gao S, Liang CZ. Eriocalyxin B ameliorated experimental autoimmune prostatitis via modulation of macrophage polarization through gut microbiota-mediated vitamin D alteration. Phytomedicine. 2024;135:156191. doi:10.1016/j.phymed.2024.156191
- Fondelli F, Willemyns J, Domenech-Garcia R, Mansilla MJ, Godoy-Tena G, et al. Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis. J Clin Invest. 2024;134. doi:10.1172/JCI178949
- Grove-Laugesen D, Ebbehoj E, Watt T, Hansen KW, Rejnmark L. Changes in bone density and microarchitecture following treatment of Graves' disease and the effects of vitamin D supplementation. A randomized clinical trial. Osteoporos Int. 2024;35:2153. doi:10.1007/s00198-024-07241-y
- Zhang Q, He X, Chen W, Jiu J, Gao C, et al. Vitamin D3 attenuates autoimmune thyroiditis by regulating Th17/Treg cell differentiation via YAP/JAK1/STAT1 axis. Immunol Lett. 2024;269:106890. doi:10.1016/j.imlet.2024.106890
- Rodi M, de Lastic AL, Panagoulias I, Aggeletopoulou I, Kelaidonis K, et al. Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis. Int J Mol Sci. 2024;25. doi:10.3390/ijms25116092
- Maghbooli Z, Shirvani A, Moghadasi AN, Varzandi T, Hamtaei Ghashti S, et al. Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot study. Mult Scler Relat Disord. 2024;87:105673. doi:10.1016/j.msard.2024.105673
- Fasihi M, Samimi-Badabi M, Robat-Jazi B, Bitarafan S, Moghadasi AN, et al. Immunoregulatory Effects of the Active Form of Vitamin D (Calcitriol), Individually and in Combination with Curcumin, on Peripheral Blood Mononuclear Cells (PBMCs) of Multiple Sclerosis (MS) Patients. Antiinflamm Antiallergy Agents Med Chem. 2024;23:138. doi:10.2174/0118715230293847240314073359
- Durá-Travé T, Gallinas-Victoriano F. Autoimmune Thyroiditis and Vitamin D. Int J Mol Sci. 2024;25. doi:10.3390/ijms25063154
- Qu F, Zhang M, Weinstock-Guttman B, Zivadinov R, Qu J, et al. An ultra-sensitive and high-throughput trapping-micro-LC-MS method for quantification of circulating vitamin D metabolites and application in multiple sclerosis patients. Sci Rep. 2024;14:5545. doi:10.1038/s41598-024-55939-0
- Ji P, Qiu S, Huang J, Wang L, Wang Y, et al. Hydrolysis of 2D Nanosheets Reverses Rheumatoid Arthritis Through Anti-Inflammation and Osteogenesis. Adv Mater. 2025;37:e2415543. doi:10.1002/adma.202415543
